British Society Allergy and Clinical Immunology Conference (BSCAI 2024)
Oct 2 - Oct 5, 2024
- Title: Efficacy and Safety of Oral Deucrictibant, a Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
Presenter: Padmalal Gurugama, M.D.
Format: Oral Presentation, and Poster Presentation
Date, time: Oral on Friday, Oct. 4, 11:20-12:30 BST (6:20-7:30 a.m. EDT); Poster Walk B, Friday, Oct. 4, 10:40-11:15 BST (5:40-6:15 a.m. EDT)
- Title: Prophylactic Treatment With Oral Deucrictibant Improves Health-Related Quality of Life in Patients With Hereditary Angioedema
Presenter: Padmalal Gurugama, M.D.
Format: Poster Presentation
Date, time: Poster Walk B – Friday, Oct. 4, 10:40-11:15 BST (5:40-6:15 a.m. EDT)
- Title: Relief and Resolution of Hereditary Angioedema Attack Symptoms Following On-Demand Treatment With a Single Dose of Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule
Presenter: Michael Tarzi, M.D.
Format: Poster Presentation
Date, time: Poster Walk B – Friday, Oct. 4, 10:40-11:15 BST (5:40-6:15 a.m. EDT)